As mRNA technology moves past COVID-19, Moderna's Phase 3 trial for a bird flu vaccine in 2025 shows how quickly we can respond, matching CEPI's goal to deliver pandemic vaccines within 100 days of identifying a threat—changing the way we protect global health
Read More